Literature DB >> 26689784

Specification Issues in a Big Data Context: Controlling for the Endogeneity of Consumer and Provider Behaviours in Healthcare Treatment Effects Models.

William H Crown1.   

Abstract

Mesh：

Year:  2016        PMID： 26689784     DOI： 10.1007/s40273-015-0362-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  16 in total

1.  Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Authors:  Donald G Klepser; Jeffrey R Huether; Lee J Handke; Clint E Williams
Journal:  J Manag Care Pharm       Date:  2007 Nov-Dec

2.  Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.

Authors:  Joseph V Terza; Anirban Basu; Paul J Rathouz
Journal:  J Health Econ       Date:  2007-12-04       Impact factor: 3.883

3.  Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.

Authors:  Christine E Bishop; Andrew M Ryan; Daniel M Gilden; Joanna Kubisiak; Cindy Parks Thomas
Journal:  Health Serv Res       Date:  2009-03-02       Impact factor: 3.402

4.  Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Authors:  Boyd H Gilman; John Kautter
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

Review 5.  Potential application of machine learning in health outcomes research and some statistical cautions.

Authors:  William H Crown
Journal:  Value Health       Date:  2015-01-29       Impact factor: 5.725

6.  Rapid learning: a breakthrough agenda.

Authors:  Lynn M Etheredge
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

Review 7.  Instrumental variable methods in comparative safety and effectiveness research.

Authors:  M Alan Brookhart; Jeremy A Rassen; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

8.  Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.

Authors:  Anirban Basu; James J Heckman; Salvador Navarro-Lozano; Sergio Urzua
Journal:  Health Econ       Date:  2007-11       Impact factor: 3.046

9.  Optum Labs: building a novel node in the learning health care system.

Authors:  Paul J Wallace; Nilay D Shah; Taylor Dennen; Paul A Bleicher; Paul D Bleicher; William H Crown
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

10.  Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.

Authors:  William H Shrank; Margaret Stedman; Susan L Ettner; Dee DeLapp; June Dirstine; M Alan Brookhart; Michael A Fischer; Jerry Avorn; Steven M Asch
Journal:  J Gen Intern Med       Date:  2007-07-24       Impact factor: 5.128
View more
  1 in total

1.  Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis.

Authors:  Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.